Home » Newsletters » BioWorld

BioWorld

Jan. 23, 1992

View Archived Issues

CALGENE TO TEST LAURATE-PRODUCING PLANT

DNAP TOMATOES RESIST ROT

USDA OKS CARRINGTON VACCINE ADJUVANT

LIDAK CANCELS PLANS FOR SUBSIDIARY

DOCTORS BLAST AMGEN'S G-CSF TRIAL

YAMANOUCHI TO BUY STAKE IN ROBERTS

SOMATIX GETS PATENT FOR GENE THERAPY

GILEAD IPO RAISES $86.25 MILLION

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026